Global Hepatitis B Vaccine (Recombinant) Market Research Report 2021

1 Hepatitis B Vaccine (Recombinant) Market Overview

• 1.1 Product Overview and Scope of Hepatitis B Vaccine (Recombinant)
• 1.2 Hepatitis B Vaccine (Recombinant) Segment by Type
  • 1.2.1 Global Hepatitis B Vaccine (Recombinant) Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 10mcg/0.5ml
  • 1.2.3 10mcg/ml
• 1.3 Hepatitis B Vaccine (Recombinant) Segment by Application
  • 1.3.1 Hepatitis B Vaccine (Recombinant) Sales Comparison by Application: (2021-2027)
  • 1.3.2 Newborn
  • 1.3.3 Adult
• 1.4 Global Hepatitis B Vaccine (Recombinant) Market Size Estimates and Forecasts
  • 1.4.1 Global Hepatitis B Vaccine (Recombinant) Revenue 2016-2027
  • 1.4.2 Global Hepatitis B Vaccine (Recombinant) Sales 2016-2027
  • 1.4.3 Hepatitis B Vaccine (Recombinant) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Hepatitis B Vaccine (Recombinant) Market Competition by Manufacturers

• 2.1 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Hepatitis B Vaccine (Recombinant) Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Hepatitis B Vaccine (Recombinant) Manufacturing Sites, Area Served, Product Type
• 2.5 Hepatitis B Vaccine (Recombinant) Market Competitive Situation and Trends
  • 2.5.1 Hepatitis B Vaccine (Recombinant) Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Hepatitis B Vaccine (Recombinant) Players Market Share by Revenue
  • 2.5.3 Global Hepatitis B Vaccine (Recombinant) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Hepatitis B Vaccine (Recombinant) Retrospective Market Scenario by Region

• 3.1 Global Hepatitis B Vaccine (Recombinant) Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Hepatitis B Vaccine (Recombinant) Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Hepatitis B Vaccine (Recombinant) Market Facts & Figures by Country
  • 3.3.1 North America Hepatitis B Vaccine (Recombinant) Sales by Country
  • 3.3.2 North America Hepatitis B Vaccine (Recombinant) Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Hepatitis B Vaccine (Recombinant) Market Facts & Figures by Country
  • 3.4.1 Europe Hepatitis B Vaccine (Recombinant) Sales by Country
  • 3.4.2 Europe Hepatitis B Vaccine (Recombinant) Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Hepatitis B Vaccine (Recombinant) Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Region
  • 3.5.2 Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Hepatitis B Vaccine (Recombinant) Market Facts & Figures by Country
  • 3.6.1 Latin America Hepatitis B Vaccine (Recombinant) Sales by Country
  • 3.6.2 Latin America Hepatitis B Vaccine (Recombinant) Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Country
  • 3.7.2 Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Hepatitis B Vaccine (Recombinant) Historic Market Analysis by Type

• 4.1 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2016-2021)
• 4.2 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Type (2016-2021)
• 4.3 Global Hepatitis B Vaccine (Recombinant) Price by Type (2016-2021)

5 Global Hepatitis B Vaccine (Recombinant) Historic Market Analysis by Application

• 5.1 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2016-2021)
• 5.2 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Application (2016-2021)
• 5.3 Global Hepatitis B Vaccine (Recombinant) Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 GSK
  • 6.1.1 GSK Corporation Information
  • 6.1.2 GSK Description and Business Overview
  • 6.1.3 GSK Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 GSK Product Portfolio
  • 6.1.5 GSK Recent Developments/Updates
• 6.2 Merck
  • 6.2.1 Merck Corporation Information
  • 6.2.2 Merck Description and Business Overview
  • 6.2.3 Merck Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Merck Product Portfolio
  • 6.2.5 Merck Recent Developments/Updates
• 6.3 Sanofi Pasteur
  • 6.3.1 Sanofi Pasteur Corporation Information
  • 6.3.2 Sanofi Pasteur Description and Business Overview
  • 6.3.3 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Sanofi Pasteur Product Portfolio
  • 6.3.5 Sanofi Pasteur Recent Developments/Updates
• 6.4 Dynavax Technologies
  • 6.4.1 Dynavax Technologies Corporation Information
  • 6.4.2 Dynavax Technologies Description and Business Overview
  • 6.4.3 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Dynavax Technologies Product Portfolio
  • 6.4.5 Dynavax Technologies Recent Developments/Updates
• 6.5 LG Life Sciences
  • 6.5.1 LG Life Sciences Corporation Information
  • 6.5.2 LG Life Sciences Description and Business Overview
  • 6.5.3 LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 LG Life Sciences Product Portfolio
  • 6.5.5 LG Life Sciences Recent Developments/Updates
• 6.6 KM Biologics
  • 6.6.1 KM Biologics Corporation Information
  • 6.6.2 KM Biologics Description and Business Overview
  • 6.6.3 KM Biologics Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 KM Biologics Product Portfolio
  • 6.6.5 KM Biologics Recent Developments/Updates
• 6.7 Shenzhen Kangtai Biological Products
  • 6.6.1 Shenzhen Kangtai Biological Products Corporation Information
  • 6.6.2 Shenzhen Kangtai Biological Products Description and Business Overview
  • 6.6.3 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Shenzhen Kangtai Biological Products Product Portfolio
  • 6.7.5 Shenzhen Kangtai Biological Products Recent Developments/Updates
• 6.8 Serum Institute
  • 6.8.1 Serum Institute Corporation Information
  • 6.8.2 Serum Institute Description and Business Overview
  • 6.8.3 Serum Institute Hepatitis B Vaccine (Recombinant) Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Serum Institute Product Portfolio
  • 6.8.5 Serum Institute Recent Developments/Updates

7 Hepatitis B Vaccine (Recombinant) Manufacturing Cost Analysis

• 7.1 Hepatitis B Vaccine (Recombinant) Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Hepatitis B Vaccine (Recombinant)
• 7.4 Hepatitis B Vaccine (Recombinant) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Hepatitis B Vaccine (Recombinant) Distributors List
• 8.3 Hepatitis B Vaccine (Recombinant) Customers

9 Hepatitis B Vaccine (Recombinant) Market Dynamics

• 9.1 Hepatitis B Vaccine (Recombinant) Industry Trends
• 9.2 Hepatitis B Vaccine (Recombinant) Growth Drivers
• 9.3 Hepatitis B Vaccine (Recombinant) Market Challenges
• 9.4 Hepatitis B Vaccine (Recombinant) Market Restraints

10 Global Market Forecast

• 10.1 Hepatitis B Vaccine (Recombinant) Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Hepatitis B Vaccine (Recombinant) by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Hepatitis B Vaccine (Recombinant) by Type (2022-2027)
• 10.2 Hepatitis B Vaccine (Recombinant) Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Hepatitis B Vaccine (Recombinant) by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Hepatitis B Vaccine (Recombinant) by Application (2022-2027)
• 10.3 Hepatitis B Vaccine (Recombinant) Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Hepatitis B Vaccine (Recombinant) by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Hepatitis B Vaccine (Recombinant) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List